Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
10/24/2001 | EP1148135A2 Cytochrome P450 monooxygenase and NADPH cytochrome P450 oxidoreductase genes and proteins related to the omega hydroxylase complex of Candida tropicalis and methods relating thereto |
10/24/2001 | EP1148134A2 Cytochrome P450 monooxygenase and NADPH cytochrome P450 oxidoreductase genes and proteins related to the omega hydroxylase complex of Candida tropicalis and methods relating thereto |
10/24/2001 | EP1148133A2 Cytochrome P450 monooxygenase and NADPH cytochrome P450 oxidoreductase genes and proteins related to the omega hydroxylase complex of Candida tropicalis and methods relating thereto |
10/24/2001 | EP1148132A2 Cytochrome P450 monooxygenase and NADPH cytochrome P450 oxidoreductase genes and proteins related to the omega hydroxylase complex of Candida tropicalis and methods relating thereto |
10/24/2001 | EP1148131A2 Cytochrome P450 monooxygenase and NADPH cytochrome P450 oxidoreductase genes and proteins related to the omega hydroxylase complex of Candida tropicalis and methods relating thereto |
10/24/2001 | EP1148130A2 Cytochrome P450 monooxygenase and NADPH cytochrome P450 oxidoreductase genes and proteins related to the omega hydroxylase complex of candida tropicalis and methods relating thereto |
10/24/2001 | EP1148129A1 Betacellulin modification |
10/24/2001 | EP1148128A1 Gene locus involved in regulating hair pigmentation, vestibular function and fertility |
10/24/2001 | EP1148127A2 Human G-protein chemokine receptor HDGNR10 (CCR5 receptor). Its uses |
10/24/2001 | EP1148126A2 Human G-protein chemokine receptor HDGNR10 (CCR5 receptor) |
10/24/2001 | EP1148125A1 Human nucleoprotein having www domain and polynucleotide encoding the same |
10/24/2001 | EP1148124A1 Cells for measuring ability to promote transcription |
10/24/2001 | EP1148123A1 Method for determining base sequence for analysis to be used in the detection of nucleic acid |
10/24/2001 | EP1148122A1 PROCESS FOR PRODUCING HMG-CoA REDUCTASE INHIBITOR |
10/24/2001 | EP1148121A1 A method for introducing recessive properties in baker's yeast |
10/24/2001 | EP1148119A1 Hybridization device, case, support, and label agent |
10/24/2001 | EP1148066A1 Use of CD34 or a polypeptide derived therefrom as cell-surface marker in gene-transfer |
10/24/2001 | EP1147422A1 Assays for modulators of "elongation factor p" activity |
10/24/2001 | EP1147413A2 Growth differentiation factor inhibitors and uses therefor |
10/24/2001 | EP1147409A1 Separation of charged particles by a spatially and temporally varying electric field |
10/24/2001 | EP1147231A1 Silent inducible virus replicons and uses thereof |
10/24/2001 | EP1147230A1 Method for controlling the extension of an oligonucleotide |
10/24/2001 | EP1147229A2 Methods for identifying drug targets based on genomic sequence data |
10/24/2001 | EP1147228A2 Method of identifying cytosine methylation patterns in genomic dna samples |
10/24/2001 | EP1147225A1 Multiplex real-time pcr |
10/24/2001 | EP1147222A1 Replicable probe array |
10/24/2001 | EP1147219A1 Analysis method |
10/24/2001 | EP1147218A1 Selection procedure using prodrug/enzyme system |
10/24/2001 | EP1147217A1 A method of dna sequencing |
10/24/2001 | EP1147213A2 Novel rgs-containing molecules and uses thereof |
10/24/2001 | EP1147211A1 High level expression of a heterologous protein having rare codons |
10/24/2001 | EP1147209A2 Gene repair involving the induction of double-stranded dna cleavage at a chromosomal target site |
10/24/2001 | EP1147208A2 Compositions and methods for intraductal gene therapy |
10/24/2001 | EP1147207A1 Transgenic plants modified to contain resveratrol glucoside and uses thereof |
10/24/2001 | EP1147206A1 Maize alternative oxidase genes and uses thereof |
10/24/2001 | EP1147205A1 High efficiency mammalian gene expression vectors that contain exogenous promoter and entire 5' untranslated region in the upstream from start codon for inherent gene as transcription regulatory site |
10/24/2001 | EP1147204A1 Composition and method for in vivo and in vitro attenuation of gene expression using double stranded rna |
10/24/2001 | EP1147203A1 Mammalian serine racemase |
10/24/2001 | EP1147202A2 Plasminogen kringle 4 region fragments and methods of use |
10/24/2001 | EP1147201A2 Metalloproteinase-disintegrin family members: svph dnas and polypeptides |
10/24/2001 | EP1147200A1 Campylobacter glycosyltransferases for biosynthesis of gangliosides and ganglioside mimics |
10/24/2001 | EP1147199A1 Nucleic acid sequences encoding isoflavone synthase |
10/24/2001 | EP1147198A1 Pyruvate carboxylase from corynebacterium glutamicum |
10/24/2001 | EP1147197A2 Schizochytrium pks genes |
10/24/2001 | EP1147196A1 Polymorphic loci that differentiate escherichia coli 0157:h7 from other strains |
10/24/2001 | EP1147195A1 Candida albicans srb-7 |
10/24/2001 | EP1147194A1 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies |
10/24/2001 | EP1147193A1 Platelet-derived growth factor/vascular endothelial growth factor-like growth factor h, and uses thereof |
10/24/2001 | EP1147192A1 Human nogo-c polynucleotide and polypeptide and their uses |
10/24/2001 | EP1147191A1 Transcriptional regulation of the human beta3-adrenergic receptor gene |
10/24/2001 | EP1147190A1 Her-2/neu fusion proteins |
10/24/2001 | EP1147189A2 Ribozyme therapy for the treatment and/or prevention of restenosis |
10/24/2001 | EP1147188A1 Internal ribosome entry site (ires), vector containing same and the uses thereof |
10/24/2001 | EP1147187A2 Endogenetic nucleic fragment associated with an autoimmune disease, marking method and reagent |
10/24/2001 | EP1147186A1 In vitro activated gamma delta lymphocytes |
10/24/2001 | EP1147185A2 Mammal, method for producing same and its use |
10/24/2001 | EP1147181A2 Telomerase reverse transcriptase transcriptional regulatory sequences |
10/24/2001 | EP1147179A2 Human liver progenitors |
10/24/2001 | EP1147178A1 Production of biomedical peptides and proteins in plants using transcomplementation systems |
10/24/2001 | EP1147174A1 Desaturases and methods of using them for synthesis of polyunsaturated fatty acids |
10/24/2001 | EP1147136A1 DNA ENCODING A MAMMALIAN RECEPTOR (fb41a) AND USES THEREOF |
10/24/2001 | EP1147134A1 Novel potassium channels and genes encoding these potassium channels |
10/24/2001 | EP1147133A2 Pth functional domain conjugate peptides, derivatives thereof and novel tethered ligand-receptor molecules |
10/24/2001 | EP1147130A1 Alpha-conotoxin peptides |
10/24/2001 | EP1147123A2 Novel odorant receptors in drosophila |
10/24/2001 | EP1147122A2 Methods for altering organ mass, controlling fertility and enhancing asexual reproduction in plants |
10/24/2001 | EP1146963A1 Nucleic acid amplification reaction station for disposable test devices |
10/24/2001 | EP1146961A1 Disposable test devices for performing nucleic acid amplification reactions |
10/24/2001 | EP1146959A1 Method and apparatus for liposome production |
10/24/2001 | EP1146909A1 Method of treating cancer by restoration of pp32 function |
10/24/2001 | EP1146908A1 Formulations comprising antisense nucleotides to connexins |
10/24/2001 | EP1146907A2 Use of cationic lipids to generate anti-tumor immunity |
10/24/2001 | EP1146900A2 Dna vaccines against hantavirus infections |
10/24/2001 | EP1146894A1 Uses of thank, a tnf homologue that activates apoptosis |
10/24/2001 | EP1146892A2 Baff, inhibitors thereof and their use in the modulation of the b-cell response |
10/24/2001 | EP1146889A2 Identification of specific differentially expressed mycobacterial antigens |
10/24/2001 | EP1146888A2 Specific therapeutic interventions obtained by interference with redistribution and/or targetting |
10/24/2001 | EP1146881A2 Preparation for the prevention and/or treatment of a tissue change of mesenchymal origin |
10/24/2001 | EP1146869A2 Inhibition of stat3 signal transduction for human cancer therapy |
10/24/2001 | EP0988307B1 Solid-phase nucleic acid isolation |
10/24/2001 | EP0952158A4 Modified methylotrophic p. pastoris yeast which secretes human groth hormone |
10/24/2001 | EP0910405B1 Vaccine containing caprine arthritis-encephalitis virus and use for immunoprotection against hiv-1 infection |
10/24/2001 | EP0809698B1 NUCLEOTIDE AND DEDUCED AMINO ACID SEQUENCES OF TUMOR GENE Int6 |
10/24/2001 | EP0801682B1 Process for the production of proteins |
10/24/2001 | EP0791077A4 Methods for modulating transcription from the amyloid beta-protein precursor (app) promoter |
10/24/2001 | EP0738332B1 Indicator cell line and method for detecting rna viruses |
10/24/2001 | EP0736099B1 Expression of self-processing polyproteins in transgenic plants |
10/24/2001 | EP0731709B1 Neutrophil inhibitors from nematodes |
10/24/2001 | EP0632828B1 ENDO-beta-1,4-GLUCANASE AND A DNA SEQUENCE |
10/24/2001 | EP0626014B1 Plant carrying genes coding for enzymes of the phytosterol biosynthesis pathway and process for the production of same |
10/24/2001 | CN1319142A Zymogenic nucleic acid detection method, and related molecules and kits |
10/24/2001 | CN1319141A Enzyme activity screen with substrate replacement |
10/24/2001 | CN1319140A Recombinant CELO virus and CELO virus DNA |
10/24/2001 | CN1319139A Polynucleotide constructs and uses thereof |
10/24/2001 | CN1319138A Pesticidal toxins and genes from i-bacillus laterosporus) strains |
10/24/2001 | CN1319137A Keratinocyte derived interferon |
10/24/2001 | CN1319136A Genes for detecting bacteria and detection method by using the same |
10/24/2001 | CN1319135A Method for making insertional mutations |
10/24/2001 | CN1319134A Genes of 1-desoxy-D-xylulose biosynthetic pathway |
10/24/2001 | CN1319132A REC2 kinase |